Oncogenic pathways impinging on the G2-restriction point

Oncogene

Volumn 27, Issue 8, 2008, Pages 1142-1154

  Foijer, F ^a,b   Simonis, M ^a   Van Vliet, M ^a,c   Wessels, L ^a,c   Kerkhoven, R ^a   Sorger, P K ^b   Te Riele, H ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Department of Microelectronics   (Netherlands)

Author keywords

c MYC; Expression profiling; G2 restriction point; Mitogenic signaling; RAS; Retinoblastoma gene family

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; CYCLIN A; CYCLIN B1; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MITOGEN ACTIVATED PROTEIN KINASE 3; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN C FOS; PROTEIN C JUN; PROTEIN KINASE B; PROTEIN MDM2; ROSCOVITINE; SERUM RESPONSE FACTOR;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; IMMUNOBLOTTING; MITOGENESIS; MULTIGENE FAMILY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SERUM; STARVATION; TUMOR SUPPRESSOR GENE; VIRUS ONCOGENE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; G2 PHASE; GENE EXPRESSION PROFILING; GENES, RAS; MICE; MULTIGENE FAMILY; ONCOGENES; RAS PROTEINS; SIGNAL TRANSDUCTION;

RATTUS;

EID: 39149093938     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210724     Document Type: Article

References (41)

1. Aleem E, Kiyokawa H, Kaldis P. (2005). Cdc2-cyclin E complexes regulate the G1/S phase transition. Nat Cell Biol 7: 831-836.
2. Alevizopoulos K, Vlach J, Hennecke S, Amati B. (1997). Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins. EMBO J 16: 5322-5333.
3. Baus F, Gire V, Fisher D, Piette J, Dulic V. (2003). Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts. EMBO J 22: 3992-4002.
4. Benjamini Y, Hochberg Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 57: 289-300.
5. Blagosklonny MV, Pardee AB. (2002). The restriction point of the cell cycle. Cell Cycle 1: 103-110.
6. Brugarolas J, Bronson RT, Jacks T. (1998). p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells. J Cell Biol 141: 503-514.
7. Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ, Der CJ. (1998). Increasing complexity of Ras signaling. Oncogene 17: 1395-1413.
8. Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, Montgomery K et al. (2004). Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol 2: E7.
9. D'Abaco GM, Hooper S, Paterson H, Marshall CJ. (2002). Loss of Rb overrides the requirement for ERK activity for cell proliferation. J Cell Sci 115: 4607-4616.
10. Dannenberg JH, van Rossum A, Schuijff L, te Riele H. (2000). Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev 14: 3051-3064.
11. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. (1995). A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92: 7686-7689.
12. Fan S, Ma Y, Gao M, Yuan R, Meng Q, Goldberg I et al. (2001). The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair. Mol Cell Biol 21: 4968-4984.
13. Feng J, Tamaskovic R, Yang Z, Brazil DP, Merlo A, Hess D et al. (2004). Stabilization of Mdm2 via decreased ubiquitination is mediated by protein kinase B/Akt-dependent phosphorylation. J Biol Chem 279: 35510-35517.
14. Foijer F, te Riele H. (2006a). Check, double check: the G2 barrier to cancer. Cell Cycle 5: 831-836.
15. Foijer F, te Riele H. (2006b). Restriction beyond the restriction point: mitogen requirement for G2 passage. Cell Div 1: 8.
16. Foijer F, Wolthuis RM, Doodeman V, Medema RH, te Riele H. (2005). Mitogen requirement for cell cycle progression in the absence of pocket protein activity. Cancer Cell 8: 455-466.
17. Guo Q, Malek R, Kim S, Chiao C, He M, Ruffy M et al. (2000). Identification of c-Myc responsive genes using rat cDNA microarray. Cancer Res 60: 5922-5928.
18. Hanahan D, Weinberg RA. (2000). The hallmarks of cancer. Cell 100: 57-70.
19. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
20. Hay N. (2005). The Akt-mTOR tango and its relevance to cancer. Cancer Cell 8: 179-183.
21. Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JC et al. (1999). The transcriptional program in the response of human fibroblasts to serum. Science 283: 83-87.
22. Knight ZA, Gonzalez B, Feldman ME, Zunder ER, Goldenberg DD, Williams O et al. (2006). A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell 125: 733-747.
23. Malumbres M, Barbacid M. (2001). To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 1: 222-231.
24. Medema RH, Kops GJ, Bos JL, Burgering BM. (2000). AFX-like forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404: 782-787.
25. Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N et al. (1997). Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases CDC2, CDK2 and CDK5. Eur J Biochem 243: 527-536.
26. Morisaki H, Fujimoto A, Ando A, Nagata Y, Ikeda K, Nakanishi M. (1997). Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (CDK) inhibitor by cyclin E/CDK2. Biochem Biophys Res Commun 240: 386-390.
27. Nakayama K, Nagahama H, Minamishima YA, Miyake S, Ishida N, Hatakeyama S et al. (2004). Skp2-mediated degradation of p27 regulates progression into mitosis. Dev Cell 6: 661-672.
28. Nigg EA. (2001). Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol 2: 21-32.
29. Oster S, Ho C, Soucie E, Penn L. (2002). Advances in Cancer Research. Academic Press, Elsevier Science & Technology Books: The Netherlands, pp 81-154.
30. Peeper DS, Dannenberg JH, Douma S, te Riele H, Bernards R. (2001). Escape from premature senescence is not sufficient for oncogenic transformation by Ras. Nat Cell Biol 3: 198-203.
31. Sage J, Mulligan GJ, Attardi LD, Miller A, Chen S, Williams B et al. (2000). Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev 14: 3037-3050.
32. Sarbassov DD, Ali SM, Sabatini DM. (2005). Growing roles for the mTOR pathway. Curr Opin Cell Biol 17: 596-603.
33. Smits VA, Klompmaker R, Arnaud L, Rijksen G, Nigg EA, Medema RH. (2000a). Polo-like kinase-1 is a target of the DNA damage checkpoint. Nat Cell Biol 2: 672-676.
34. Smits VA, Klompmaker R, Vallenius T, Rijksen G, Makela TP, Medema RH. (2000b). p21 inhibits Thr161 phosphorylation of Cdc2 to enforce the G2 DNA damage checkpoint. J Biol Chem 275: 30638-30643.
35. Sturn A, Quackenbush J, Trajanoski Z. (2002). Genesis: cluster analysis of microarray data. Bioinformatics 18: 207-208.
36. Theodosiou A, Ashworth A. (2002). MAP kinase phosphatases. Genome Biol 3: reviews3009.1-reviews3009.10.
37. Toyoshima H, Hunter T. (1994). p27, a novel inhibitor of G1 cyclin-CDK protein kinase activity, is related to p21. Cell 78: 67-74.
38. Valledor AF, Comalada M, Xaus J, Celada A. (2000). The differential time-course of extracellular-regulated kinase activity correlates with the macrophage response toward proliferation or activation. J Biol Chem 275: 7403-7409.
39. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J et al. (2002). Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 30: e15.
40. Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC. (2001). Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 3: 245-252.
41. Zhu H, Nie L, Maki C. (2005). Cdk2-dependent inhibition of p21 stability via a C-terminal cyclin-binding motif. J Biol Chem 280: 29282-29288.